Henderson G, Secor J, Heitman D, Schenker S
Dev Pharmacol Ther. 1986;9(3):201-16. doi: 10.1159/000457093.
The following studies compare developmental patterns of a hepatic monoxygenase system using (1) the aminopyrine (Ap) breath test, (2) in vivo Ap pharmacokinetics (clearances) and (3) in vitro Ap demethylation by hepatic microsomes. Together, the three methodological approaches indicate that hepatic metabolism of Ap increases from the fetal stage through 70 days of age with the male showing a significantly greater drug metabolizing capacity than the female. However, sex and developmental patterns derived by the three methodologies do not necessarily correlate quantitatively, due to a number of complex variables (i.e., liver size, drug volume of distribution, etc.) less likely encountered in the adult of fixed age and mature sexual development.
以下研究使用(1)氨基比林(Ap)呼气试验、(2)体内Ap药代动力学(清除率)以及(3)肝微粒体对Ap的体外去甲基化,比较了肝脏单加氧酶系统的发育模式。这三种方法共同表明,从胎儿期到70日龄,Ap的肝脏代谢增加,其中雄性的药物代谢能力明显高于雌性。然而,由于一些复杂变量(如肝脏大小、药物分布容积等)在固定年龄和性发育成熟的成年人中不太可能出现,三种方法得出的性别和发育模式不一定在数量上相关。